EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access

Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans

Jordan R Willis iD, Madhu Prabhakaran iD, Michelle Muthui iD, Ansuya Naidoo iD, Troy Sincomb iD, Weiwei Wu iD, Christopher A Cottrell iD, Elise Landais iD, Allan C deCamp iD, Nahid R Keshavarzi iD, Oleksandr Kalyuzhniy iD, Jeong Hyun Lee iD und 48 weitere

Science · 31.07.2025 · 389 (6759)

DOI: 10.1126/science.adr8382 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Science, erschienen am 31.07.2025. Verfasst von Jordan R Willis und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA. Hauptthemen laut MEDLINE: AIDS Vaccines, Broadly Neutralizing Antibodies, HIV Antibodies, HIV Infections. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A leading HIV vaccine strategy requires a priming immunogen to induce broadly neutralizing antibody (bnAb) precursors, followed by a series of heterologous boosters to elicit somatic hypermutation (SHM) and produce bnAbs. In two randomized, open-label phase 1 human clinical trials, IAVI G002 in the United States and IAVI G003 in Rwanda and South Africa (IAVI, International Aids Vaccine Initiative), we evaluated the safety and immunogenicity of mRNA-encoded nanoparticles as priming immunogens (both trials) and first-boosting immunogens (IAVI G002). The vaccines were generally safe and well tolerated, except that 18% of IAVI G002 participants experienced skin reactions. Priming induced bnAb precursors with substantial frequencies and SHM; heterologous boosting elicited increased SHM, affinity, and neutralization activity toward bnAb development; and elicited antibodies exhibited precise bnAb structural mimicry. The results establish clinical proof of concept that heterologous boosting can advance bnAb precursor maturation and demonstrate bnAb priming in Africa, where the HIV burden is highest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesBroadly Neutralizing AntibodiesHIV AntibodiesHIV InfectionsHIV-1mRNA VaccinesNanovaccinesAdultFemaleHumansMaleYoung AdultImmunization, SecondaryImmunogenicity, VaccineRwandaSomatic Hypermutation, ImmunoglobulinSouth AfricaVaccination

Substanzen

AIDS VaccinesBroadly Neutralizing AntibodiesHIV AntibodiesmRNA VaccinesNanovaccines

Autor:innen und Institutionen

  • Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.
  • IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.
  • IAVI, New York, NY, USA.

ORCID-Profile: Jordan R Willis, Madhu Prabhakaran, Michelle Muthui, Ansuya Naidoo, Troy Sincomb, Weiwei Wu, Christopher A Cottrell, Elise Landais, Allan C deCamp, Nahid R Keshavarzi, Oleksandr Kalyuzhniy, Jeong Hyun Lee, Nicole L Yates, Martin M Corcoran, Swastik Phulera, Yiakon Sein, Michael Muteti, Drienna Holman, Sunny Himansu, Caroline Reuter, Li-An Lin, Baoyu Ding, Kellie J MacPhee, John N Kimotho, Caleb Kibet, Hongmei Gao, Erica Beatman, Kiara Benson, David M Brown, Rhianna Bronson, Jalen Jean-Baptiste, Suprabhath Gajjala, Zahra Rikhtegaran-Tehrani, Alison Benner, Mukundhan Ramaswami, Danny Lu, Nushin Alavi, Ryan Tingle, Erik Georgeson, Nicole Phelps, Yumiko Adachi, Alessia Liguori

Förderung

  • NIAID NIH HHS
  • Bill & Melinda Gates Foundation

Zitieren

APA

Willis, J. R., Prabhakaran, M., Muthui, M., Naidoo, A., Sincomb, T., Wu, W., Cottrell, C. A., Landais, E., deCamp, A. C., Keshavarzi, N. R., Kalyuzhniy, O., Lee, J. H., Murungi, L. M., Ogonda, W. A., Yates, N. L., Corcoran, M. M., Phulera, S., Musando, J., Tsai, A., …, & Liguori, A. (2025). Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science, 389(6759). https://doi.org/10.1126/science.adr8382

Vancouver

Willis JR, Prabhakaran M, Muthui M, Naidoo A, Sincomb T, Wu W, et al. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science. 2025;389(6759). doi:10.1126/science.adr8382

BibTeX
@article{Willis2025,
  author = {Willis, Jordan R and Prabhakaran, Madhu and Muthui, Michelle and Naidoo, Ansuya and Sincomb, Troy and Wu, Weiwei and Cottrell, Christopher A and Landais, Elise and deCamp, Allan C and Keshavarzi, Nahid R and Kalyuzhniy, Oleksandr and Lee, Jeong Hyun and Murungi, Linda M and Ogonda, Wilfrida A and Yates, Nicole L and Corcoran, Martin M and Phulera, Swastik and Musando, Joel and Tsai, Amanda and Lemire, Gabrielle and Sein, Yiakon and Muteti, Michael and Alamuri, Praveen and Bohl, Jennifer A and Holman, Drienna and Himansu, Sunny and Leav, Brett and Reuter, Caroline and Lin, Li-An and Ding, Baoyu and He, Chunla and Straus, Walter L and MacPhee, Kellie J and Regadas, Isabel and Nyabundi, Diana V and Chirchir, Ruth and Anzala, Omu and Kimotho, John N and Kibet, Caleb and Greene, Kelli and Gao, Hongmei and Beatman, Erica and Benson, Kiara and Laddy, Dominick and Brown, David M and Bronson, Rhianna and Jean-Baptiste, Jalen and Gajjala, Suprabhath and Rikhtegaran-Tehrani, Zahra and Benner, Alison and Ramaswami, Mukundhan and Lu, Danny and Alavi, Nushin and Amirzehni, Sonya and Kubitz, Michael and Tingle, Ryan and Georgeson, Erik and Phelps, Nicole and Adachi, Yumiko and Liguori, Alessia},
  title = {Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans},
  journal = {Science},
  year = {2025},
  volume = {389},
  number = {6759},
  doi = {10.1126/science.adr8382}
}
Kostenlos starten →